Adrenal gland - Strong and diffuse PGP9.5 immunostaining in all tumor cells of a pheochromocytoma.
Breast - PGP9.5 negative breast cancer of no special type (NST).
Colon - PGP9.5 negative colorectal adenocarcinoma. A positive staining is seen in nerve fibres.
Esophagus - PGP9.5 negative adenocarcinoma.
Kidney - Chromophobe renal cell carcinoma showing variable intensity PGP9.5 staining in tumor cells (mosaic pattern).
Kidney - PGP9.5 negative clear cell carcinoma.
Larynx - Squamous cell carcinoma showing strong PGP9.5 positivity in tumor cells.
Liposarcoma with moderate intensity PGP9.5 immunostaining.
Liver - Cholangiocellular carcinoma showing PGP9.5 immunostaining of variable intensity in cancer cells (mosaic pattern).
Oral cavity - Squamous cell carcinoma showing strong PGP9.5 positivity in most tumor cells.
Ovary - Endometroid carcinoma with strong PGP9.5 staining in most tumor cells.
Ovary - Serous high-grade carcinoma showing variable intensity PGP9.5 staining in tumor cells (mosaic pattern).
Ovary - Serous high-grade carcinoma with moderate to strong PGP9.5 staining in tumor cells.
Pancreas - Neuroendocrine tumor with strong diffuse PGP9.5 immunostaining.
Pancreas - Neuroendocrine tumor with weak PGP9.5 immunostaining in only a few tumor cells.
Pleura - Malignant (epitheloid) mesothelioma with PGP9.5 immunostaining of variable intensity (mosaic pattern).
Pleura - Strong PGP9.5 immunostaining in a malignant (epitheloid) mesothelioma.
Prostate - PGP9.5 negative adenocarcinoma (Gleason 3+3=6).
Skin - Merkel cell carcinoma showing strong PGP9.5 immunostaining.
Stomach - PGP9.5 negative adenocarcinoma (intestinal type).
Testis - Embryonal carcinoma showing a moderate to strong PGP9.5 immunostaining in cancer cells.
Testis - Seminoma showing a strong PGP9.5 immunostaining in tumor cells.
Testis - Seminoma with variable intensity PGP9.5 staining in tumor cells (mosaic pattern).
Testis - Seminoma with weak to moderate PGP9.5 staining in tumor cells.
Thyroid - Anaplastic carcinoma with moderate to strong PGP9.5 positivity in tumor cells.
Thyroid - Medullary carcinoma showing strong PGP9.5 immunostaining.
Urinary bladder - Muscle-invasive urothelial carcinoma showing PGP9.5 immunostaining of variable intensity in cancer cells (mosaic pattern).